English | Español

Astrazeneca Pharmaceuticals Lp
Gene Johnson | Feb 19, 2017

AstraZeneca touts results of breast cancer drug
+ Technology/Innovation
Amanda Rupp | Sep 10, 2016

Benralizumab Phase III trials have positive results for severe asthma
+ Regulatory
Amanda Rupp | Jun 28, 2016

AstraZeneca releases update on FluMist vaccine
+ Regulatory
Amanda Rupp | Jun 5, 2016

AstraZeneca completes U.S. licensing agreement for Zurampic
+ Technology/Innovation
Amanda Rupp | May 23, 2016

AstraZeneca emphasizes oncology pipeline progress
+ Technology/Innovation
Amanda Rupp | May 22, 2016

AstraZeneca releases positive outcomes from severe asthma study
+ Technology/Innovation
Amanda Rupp | May 22, 2016

One Brave Idea names 10 leading finalists
+ Regulatory
Amanda Rupp | May 12, 2016

MedImmune gains Fast Track designation for flu treatment

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes